{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-030375","form_type":"8-K","ticker":"GMED","cik":"0001237831","company_name":"GLOBUS MEDICAL INC","filed_at":"2023-02-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.136631+00:00","generated_at":"2026-06-19T19:28:50.304762+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Globus Medical to acquire NuVasive in all-stock merger; each NuVasive share gets 0.75 GMED share","bullets":["Each NuVasive share converted into 0.75 Globus Medical Class A common shares; no cash consideration except fractional shares.","Expected close by Oct 8, 2023, extendable to Feb 8, 2024; subject to HSR, shareholder approvals, and other conditions.","Termination fees: NuVasive pays $120M (reduced to $75M in Specified Period); Globus pays $120M in certain scenarios.","Globus board expanded to 11 members; 3 NuVasive directors to be appointed post-close.","David & Sonali Paul (70% voting power) agree to vote Globus Class B shares in favor of issuance."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-030375","json":"https://secwatch.observer/filing/0001193125-23-030375.json","markdown":"https://secwatch.observer/filing/0001193125-23-030375.md","text":"https://secwatch.observer/filing/0001193125-23-030375.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1237831/000119312523030375/0001193125-23-030375-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1237831/000119312523030375/d447800d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T19:28:50.304762+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ef2bd120f197496a34495ac9b2c29b0898b5889f","claim":"GLOBUS MEDICAL INC entered into Agreement and Plan of Merger with NuVasive, Inc. (effective 2023-02-08).","evidence_excerpt":"On February 8, 2023, NuVasive, Inc., a Delaware corporation (“NuVasive”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Globus Medical, Inc., a Delaware corporation (“Globus Medical”) and Zebra Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Globus Medical (“Merger Sub”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1237831/000119312523030375/0001193125-23-030375-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"NuVasive, Inc."},{"label":"Effective","value":"2023-02-08"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}